Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Morphosys Ag ADR (NQ: MOR ) 18.96 UNCHANGED Last Price Updated: 4:00 PM EDT, Aug 2, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Morphosys Ag ADR < Previous 1 2 ... 4 5 6 7 8 9 10 11 Next > 12 Health Care Stocks Moving In Wednesday's Pre-Market Session July 07, 2021 Gainers Dare Bioscience (NASDAQ:DARE) shares increased by 51.97% to $2.31 during Wednesday's pre-market session. The market value of their outstanding shares is at $... Via Benzinga MorphoSys Announces Expiration of the Hart-Scott-Rodino Waiting Period for Acquisition of Constellation Pharmaceuticals July 01, 2021 MUNICH, GERMANY and WILMINGTON, DE / ACCESSWIRE / July 1, 2021 / MorphoSys AG (FSE:MOR) (NASDAQ:MOR) ("MorphoSys") today announced the expiration of the waiting period under the Hart-Scott-Rodino... From MorphoSys AG Via AccessWire Exposures Product Safety MorphoSys and Incyte Announce Positive CHMP Opinion for Tafasitamab in Combination with Lenalidomide for the Treatment of Adults with Relapsed or Refractory Diffuse Large B-Cell Lymphoma June 25, 2021 - If approved, tafasitamab in combination with lenalidomide would represent an important new therapeutic option for eligible DLBCL patients in the European Union - The positive opinion from the CHMP is... From MorphoSys AG Via AccessWire Exposures COVID-19 Product Safety Incyte and MorphoSys Announce Positive CHMP Opinion for Tafasitamab in Combination with Lenalidomide for the Treatment of Adults with Relapsed or Refractory Diffuse Large B-Cell Lymphoma June 25, 2021 From Incyte Via Business Wire MorphoSys Commences Cash Tender Offer for All Outstanding Shares of Constellation Pharmaceuticals June 16, 2021 PLANEGG, GERMANY / ACCESSWIRE / June 16, 2021 / MorphoSys AG (FSE:MOR)(NASDAQ:MOR) ("MorphoSys") today announced that it is commencing a cash tender offer to purchase all outstanding shares of... From MorphoSys AG Via AccessWire Exposures Product Safety Benzinga's Top Ratings Upgrades, Downgrades For June 11, 2021 June 11, 2021 Upgrades Barclays upgraded the previous rating for Ventas Inc (NYSE:VTR) from Equal-Weight to Overweight. In the first quarter, Ventas showed an EPS of $0.72, compared to... Via Benzinga 10 Biggest Price Target Changes For Friday June 11, 2021 Barclays lowered Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) price target from $302 to $285. Vertex Pharmaceuticals shares fell 13.3% to $187.88 in pre-market trading.... Via Benzinga The Week Ahead In Biotech: Biogen, Alexion And Vertex FDA Decisions, Multiple Conference Presentations On The Deck June 07, 2021 Biopharma stocks advanced in the truncated week ended June 4 amid the broader market strength. The American Society for Clinical Oncology meeting got underway during the week,... Via Benzinga Exposures Product Safety MorphoSys and Incyte Announce Three-Year Results from Phase 2 L-MIND Study of Tafasitamab in Combination with Lenalidomide for the Treatment of Relapsed or Refractory DLBCL June 04, 2021 Presentation will be available on demand as part of the 2021 American Society of Clinical Oncology (ASCO) Annual Meeting BOSTON, MA and WILMINGTON, DE / ACCESSWIRE / June 4, 2021 / MorphoSys US Inc., a... From MorphoSys AG Via AccessWire Exposures COVID-19 Product Safety Why MorphoSys Stock Sank This Week June 03, 2021 Investors weren't happy about the drugmaker's wheeling and dealing. Via The Motley Fool Why Constellation Pharmaceuticals Stock Was Crushing It This Week June 03, 2021 The small drugmaker is being acquired by MorphoSys. Via The Motley Fool The Daily Biotech Pulse: Merck Completes Organon Spin-Off, Auris Repositions As RNA Therapeutic Company With Trasir Purchase, Replimune's Readout June 03, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 2) BioCryst Pharmaceuticals,... Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For June 3, 2021 June 03, 2021 Upgrades According to B of A Securities, the prior rating for Bloom Energy Corp (NYSE:BE) was changed from Underperform to Neutral. For the first quarter, Bloom Energy had... Via Benzinga Mid-Afternoon Market Update: Constellation Pharmaceuticals Surges Following Acquisition News; Protalix BioTherapeutics Shares Slide June 02, 2021 Toward the end of trading Wednesday, the Dow traded up 0.05% to 34,594.18 while the NASDAQ fell 0.16% to 13,715.08. The S&P also rose, gaining 0.02% to 4,202.76. The U.S. has... Via Benzinga Topics Stocks Exposures US Equities 66 Biggest Movers From Yesterday June 03, 2021 Gainers AMC Entertainment Holdings, Inc. (NYSE: AMC) surged 95.2% to close at $62.55 on Wednesday amid renewed interest from retail investors. AMC Entertainment shares jumped... Via Benzinga 12 Health Care Stocks Moving In Wednesday's Intraday Session June 02, 2021 Gainers Constellation (NASDAQ:CNST) shares rose 67.19% to $33.84 during Wednesday's regular session. As of 12:30 EST, this security is trading at a volume of 19.5... Via Benzinga Mid-Day Market Update: Crude Oil Rises 1%; iRhythm Technologies Shares Plunge June 02, 2021 `Midway through trading Wednesday, the Dow traded up 0.33% to 34,689.77 while the NASDAQ rose 0.16% to 13,758.43. The S&P also rose, gaining 0.30% to 4,214.55. The U.S. has... Via Benzinga Topics Stocks Exposures Fossil Fuels US Equities Why Constellation Pharmaceuticals Stock Is Skyrocketing Today June 02, 2021 The company is being acquired by MorphoSys. Via The Motley Fool 40 Stocks Moving In Wednesday's Mid-Day Session June 02, 2021 Gainers BriaCell Therapeutics Corp. (NASDAQ: BCTX) shares jumped 147.3% to $7.86 after the company provided an update on the overall survival (OS) data on its previously... Via Benzinga Mid-Morning Market Update: Markets Open Higher; Advance Auto Parts Profit Tops Estimates June 02, 2021 Following the market opening Wednesday, the Dow traded up 0.26% to 34,665.01 while the NASDAQ rose 0.15% to 13,757.62. The S&P also rose, gaining 0.23% to 4,211.85. The U.S.... Via Benzinga Topics Stocks Exposures US Equities Stocks That Hit 52-Week Lows On Wednesday June 02, 2021 Before 10 a.m. ET on Wednesday, 8 companies hit new 52-week lows. Highlights: Dun & Bradstreet Hldgs (NYSE:DNB) was the biggest company by market cap to set a new 52-... Via Benzinga Constellation Pharma Rockets On Word Of $1.7 Billion MorphoSys Takeover June 02, 2021 MorphoSys announced its $1.7 billion plan to acquire cancer treatment biotech Constellation on Wednesday and CNST stock rocketed to a four-month high. Via Investor's Business Daily Why Constellation Pharmaceuticals Is Soaring Today June 02, 2021 Constellation Pharmaceuticals Inc (NASDAQ: CNST) is trading higher Wednesday morning after an announcement that MorphoSys AG (NASDAQ: MOR) will acquire the company. What Happened... Via Benzinga MorphoSys to Acquire Constellation Pharma at $34/Share; Enters $2B Strategic Funding with Royalty Pharma June 02, 2021 MorphoSys AG (NASDAQ: MOR) has agreed to acquire Constellation Pharmaceuticals Inc (NASDAQ: CNST) for $34/share in cash, representing a total equity value of... Via Benzinga 12 Health Care Stocks Moving In Wednesday's Pre-Market Session June 02, 2021 Gainers Constellation (NASDAQ:CNST) shares moved upwards by 66.55% to $33.71 during Wednesday's pre-market session. The market value of their outstanding shares is at... Via Benzinga MorphoSys AG to Acquire Constellation Pharmaceuticals and Enter into Strategic Funding Partnership with Royalty Pharma June 02, 2021 MUNICH, GERMANY and CAMBRIDGE, MA / ACCESSWIRE / June 2, 2021 / MorphoSys AG (FSE:MOR) (NASDAQ:MOR) ("MorphoSys"), announces today that it has entered into a definitive agreement with Constellation... From MorphoSys AG Via AccessWire Topics Regulatory Compliance Exposures Legal Product Safety Regulatory MorphoSys to Acquire Constellation Pharmaceuticals June 02, 2021 From MorphoSys AG Via Business Wire Benzinga's Top Ratings Upgrades, Downgrades For May 24, 2021 May 24, 2021 Upgrades Seaport Global upgraded the previous rating for Public Service Enterprise Group Inc (NYSE:PEG) from Neutral to Buy. Public Service Enterprise earned $1.28 in the... Via Benzinga MorphoSys To Participate in UBS Global Healthcare Conference May 21, 2021 PLANEGG/MUNICH, GERMANY / ACCESSWIRE / May 21, 2021 / MorphoSys AG (FSE:MOR)(NASDAQ:MOR) today announced that Jean-Paul Kress, M.D., the company's Chief Executive Officer, will participate in a... From MorphoSys AG Via AccessWire MorphoSys to Present Data on Tafasitamab (Monjuvi(R)) at the 2021 ASCO Annual Meeting May 19, 2021 PLANEGG/MUNICH, GERMANY / ACCESSWIRE / May 19, 2021 / MorphoSys AG (FSE:MOR)(NASDAQ:MOR) today announced that new data from the tafasitamab (Monjuvi(R)) development program will be presented at the... From MorphoSys AG Via AccessWire Exposures COVID-19 Product Safety < Previous 1 2 ... 4 5 6 7 8 9 10 11 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
